PRESENTATION: From Chemistry to Consequence: Approaching Protein Degradation from Both Sides with Human E3scan™ Target-based and BioMAP® Phenotypic Platforms
Date & Time
Tuesday, February 16, 2021, 11:05 AM - 11:35 AM
Ksenya Cohen Katsenelson Alison O’Mahony

Expand and enhance your Targeted Protein Degradation strategy beyond conventional approaches with Eurofins Discovery’s innovative portfolio featuring E3scan™ technology and human-centric phenotypic profiling. Selectively screen E3 ligase substrate domains with robust, reproducible and high throughput assays. Evaluate targeted protein degraders using the BioMAP® Phenotypic Platform to gain translational insights by comparing biomarker activity profiles with key benchmarks. Together these approaches support SAR discovery strategies, guide hit selection and drive candidate progression.

Virtual Session Link